Rheumatology Book

http://www.fpnotebook.com/

Allopurinol

Aka: Allopurinol, Zyloprim, Xanthine oxidase inhibitor
Advertisement
  1. Indications
    1. Gout Prophylaxis
      1. Uric Acid over-producers (Uric Acid > 750 mg/24h)
      2. Used in Uric Acid under-excreters as well
    2. Criteria
      1. Recurrent episode of gout (>3 attacks per year)
      2. Tophaceous gout
      3. Nephrolithiasis
  2. Precautions
    1. Avoid in acute gout attack (wait at least 4-6 weeks after acute attack)
    2. Avoid use with Azathioprine (causes toxic levels)
    3. Avoid in Renal Failure (or use low dose)
    4. Do not use for asymptomatic Hyperuricemia
  3. Mechanism: Xanthine oxidase inhibitor
    1. Inhibits Uric Acid formation
  4. Dosing
    1. Use concurrent antiinflammatory agent when starting to prevent triggering attack
      1. Wait to start Allopurinol until at least 6-8 weeks symptom-free from last attack
      2. Antiinflammatory agent options to start concurrently with Allopurinol (continue for first 3-6 months)
        1. NSAIDS (avoid in Chronic Kidney Disease, heart disease or liver disease)
          1. Aleve 220 mg (OTC) orally twice daily or
          2. Naprosyn 250 mg orally twice daily or
          3. Indomethacin 25 mg orally twice daily
        2. Prednisone (if NSAIDs contraindicated)
          1. Maintenance: 10 mg orally daily, then 5 mg orally daily for 3-6 months
          2. Acute Exacerbation (start at first symptoms of gout recurrence): 40 mg orally for 1-3 days
            1. Have available as emergency prescription
        3. Colchicine
          1. Colchicine was a first line agent for this until generic preparations were removed from market (now too expensive)
          2. Colchicine 0.6 mg PO daily to twice daily
    2. Allopurinol 100-300 mg/day
      1. Use lowest dose to keep Uric Acid <6 mg/dl
      2. Initiating dose
        1. Start: 100 mg daily for 2 weeks
        2. Next: 200 mg daily for 2 weeks
        3. Next: 300 mg daily (most effective dose for most patients)
        4. Some patients require higher doses (up to 800 mg/day) to maintain Uric Acid <6 mg/dl
      3. Adjust for Renal Function
        1. GFR >90 ml/min: 300 mg daily
        2. GFR 60-89 ml/min: 200 mg daily
        3. GFR 30-59 ml/min: 100 mg daily
        4. GFR 10-29 ml/min (or Cr >1.5): 50-100 mg daily
        5. GFR <10 ml/minute: Avoid or use with caution
  5. Monitoring: Obtain 6 weeks after starting Allopurinol
    1. Complete Blood Count (CBC)
    2. Alanine Aminotransferase (ALT)
    3. Serum Creatinine
    4. Serum Uric Acid
  6. Adverse effects
    1. May precipitate acute gout attack (never start during active gout attack)
      1. See Dosing above for protocol using NSAIDs or Colchicine concurrently
    2. Hypersensitivity Syndrome (presents as dermatitis)
      1. Varies from mild rash to Stevens Johnson Syndrome
    3. Toxic Hepatitis
    4. Nausea
    5. Diarrhea
    6. Cytopenias
  7. Drug Interactions
    1. Azathioprine (toxicity)
    2. Warfarin (Allopurinal increases INR)
Medication Costs
ALLOPURINOL (on 2/10/2012 at Target.com)
ALLOPURINOL 100 MG Tablet #30 for $4.00 ($0.13/unit)
ALLOPURINOL 300 MG Tablet #30 for $4.00 ($0.13/unit)
Allopurinol (on 2/9/2012 at DrugStore.com)
Allopurinol 100mg Tablets #100 for $13.99 ($0.14/unit)
Allopurinol 300mg Tablets #100 for $23.99 ($0.24/unit)
Zyloprim (on 2/9/2012 at DrugStore.com)
Zyloprim 100mg Tablets #30 for $69.98 ($2.33/unit)
Zyloprim 300mg Tablets #30 for $103.99 ($3.47/unit)
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Zyloprim (C0701096)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D000493
English zyloric, zyloprim, Zyloric, Glaxo Wellcome Brand of Allopurinol, Wellcome Brand of Allopurinol, Allopurinol Wellcome Brand, Zyloprim
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Allopurinol (C0002144)

Definition (CHV) a kind of gout treatment drug
Definition (MSH) A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.
Definition (CSP) drug used to treat gout and other conditions in which there is an excessive buildup of uric acid.
Definition (NCI) A drug that lowers high levels of uric acid (a byproduct of metabolism) in the blood caused by some cancer treatments.
Definition (PDQ) A structural isomer of hypoxanthine. Allopurinol inhibits xanthine oxidase, an enzyme that converts oxypurines to uric acid. By blocking the production of uric acid, this agent decreases serum and urine concentrations of uric acid, thereby providing protection against uric acid-mediated end organ damage in conditions associated with excessive production of uric acid, i.e. the massive cell lysis associated with the treatment of some malignancies. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38452&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38452&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C224" NCI Thesaurus)
Definition (NCI) A structural isomer of hypoxanthine. Allopurinol inhibits xanthine oxidase, an enzyme that converts oxypurines to uric acid. By blocking the production of uric acid, this agent decreases serum and urine concentrations of uric acid, thereby providing protection against uric acid-mediated end organ damage in conditions associated with excessive production of uric acid, i.e. the massive cell lysis associated with the treatment of some malignancies. (NCI04)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D000493
SnomedCT 25246002, 387135004, 391735003
English Allopurinol, 4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol, 4-Hydroxypyrazolo[3,4-d]pyrimidine, 1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one, 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, allopurinol, 4'-HPP, allopurinol (medication), ALLOPURINOL, Allopurinol [Chemical/Ingredient], allopurinol sodium (as allopurinol), Allopurinol (product), Allopurinol (substance), ALLO, Allopurinol - chemical (substance), Allopurinol - chemical
Swedish Allopurinol
Spanish alopurinol - sustancia química, alopurinol - sustancia química (sustancia), alopurinol (producto), alopurinol (sustancia), alopurinol, Alopurinol
Czech alopurinol
Finnish Allopurinoli
Russian ALLOPURINOL, АЛЛОПУРИНОЛ
Japanese アロプリノール
Croatian ALOPURINOL
Polish Allopurinol, Zyloprin
French Allopurinol
German Allopurinol
Italian Allopurinolo
Portuguese Alopurinol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree